Cargando…
Impact of the repurposed drug thonzonium bromide on host oral-gut microbiomes
Drug repurposing is a feasible strategy for the development of novel therapeutic applications. However, its potential use for oral treatments and impact on host microbiota remain underexplored. Here, we assessed the influences of topical oral applications of a repurposed FDA-approved drug, thonzoniu...
Autores principales: | Simon-Soro, Aurea, Kim, Dongyeop, Li, Yong, Liu, Yuan, Ito, Tatsuro, Sims, Kenneth R., Benoit, Danielle S. W., Bittinger, Kyle, Koo, Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822857/ https://www.ncbi.nlm.nih.gov/pubmed/33483519 http://dx.doi.org/10.1038/s41522-020-00181-5 |
Ejemplares similares
-
Discovery and mechanism of action of Thonzonium bromide from an FDA-approved drug library with potent and broad-spectrum inhibitory activity against main proteases of human coronaviruses
por: Wang, Ruyu, et al.
Publicado: (2023) -
Human Tooth as a Fungal Niche: Candida albicans Traits in Dental Plaque Isolates
por: Xiang, Zhenting, et al.
Publicado: (2023) -
Potential implications of SARS-CoV-2 oral infection in the host microbiota
por: Xiang, Zhenting, et al.
Publicado: (2020) -
Polymicrobial Aggregates in Human Saliva Build the Oral Biofilm
por: Simon-Soro, Aurea, et al.
Publicado: (2022) -
Bacterial-derived exopolysaccharides enhance antifungal drug tolerance in a cross-kingdom oral biofilm
por: Kim, Dongyeop, et al.
Publicado: (2018)